Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer — Stella

Home/Prostate Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

China

Peking University First Hospital, Beijing, Beijing Municipality

Peking University Cancer Hospital, Beijing, Beijing Municipality

Peking University Third Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Peking University First Hospital

Enrollment target

~390 participants

Started

June 2025

Primary completion

January 2027

Age range

18 Years – 85 Years

Sex

Male only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.